Biliary Cancer: ESMO Clinical Practice Guidelines

Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v28-v37

Authors: J. W. Valle, I. Borbath, S. A. Khan, F. Huguet, T. Gruenberger and D. Arnold

Biliary tract cancer comprises <1% of all human cancers and ∼10%–15% of all primary liver cancers. They are subclassified into important subtypes including intrahepatic or extrahepatic (perihilar or distal) cholangiocarcinoma and bladder cancer, each of which has its own specific characteristics requiring individual work-up. These guidelines focus on diagnosis and pathology/molecular biology, staging and risk assessment and management of biliary cancer including follow-up and long-term implications.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings